Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer

IMPORTANCE: Black men have higher incidence and mortality from prostate cancer. Whether precision oncology disparities affect Black men with metastatic castration-resistant prostate cancer (mCRPC) is unknown. OBJECTIVE: To compare precision medicine data and outcomes between Black and White men with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Clara, Henderson, Nicholas C., Chu, Shih-Chun, Holland, Brandon, Cackowski, Frank C., Pilling, Amanda, Jang, Albert, Rothstein, Shoshana, Labriola, Matthew, Park, Joseph J., Ghose, Alyssa, Bilen, Mehmet A., Mustafa, Seema, Kilari, Deepak, Pierro, Michael J., Thapa, Bicky, Tripathi, Abhishek, Garje, Rohan, Ravindra, Aditya, Koshkin, Vadim S., Hernandez, Erik, Schweizer, Michael T., Armstrong, Andrew J., McKay, Rana R., Dorff, Tanya B., Alva, Ajjai S., Barata, Pedro C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507489/
https://www.ncbi.nlm.nih.gov/pubmed/37721753
http://dx.doi.org/10.1001/jamanetworkopen.2023.34208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507489/
https://www.ncbi.nlm.nih.gov/pubmed/37721753
http://dx.doi.org/10.1001/jamanetworkopen.2023.34208

Ejemplares similares